Molymem is a company focused on developing advanced membranes designed to improve the efficiency of separation processes, particularly in water treatment applications such as desalination and industrial contaminant removal. Their technology emphasizes the creation of membranes that offer high water permeance, selective species rejection, and resistance to corrosion. By addressing global water and wastewater challenges, Molymem aims to support industries and municipalities in minimizing their environmental impact and managing water resources more effectively.
Biorelate
Series A in 2022
Biorelate Ltd. is a biomedical research services company based in Oldham, United Kingdom, founded in 2014. The company focuses on the research and development of biomarkers for diagnosing prostate cancer, target validation, and drug development. Biorelate has developed a database platform that curates biomedical knowledge to support innovations in biotechnological research. Its platform is designed to automatically curate valuable biomedical data from various text sources, ingest information from multiple origins, and identify causal interactions between genes, chemicals, drugs, cells, and phenotypes. This functionality enhances the capabilities of scientists engaged in drug discovery and cancer diagnosis, facilitating their research efforts.
Biorelate
Venture Round in 2018
Biorelate Ltd. is a biomedical research services company based in Oldham, United Kingdom, founded in 2014. The company focuses on the research and development of biomarkers for diagnosing prostate cancer, target validation, and drug development. Biorelate has developed a database platform that curates biomedical knowledge to support innovations in biotechnological research. Its platform is designed to automatically curate valuable biomedical data from various text sources, ingest information from multiple origins, and identify causal interactions between genes, chemicals, drugs, cells, and phenotypes. This functionality enhances the capabilities of scientists engaged in drug discovery and cancer diagnosis, facilitating their research efforts.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.